Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Patient-centered Care01:13

Patient-centered Care

2.8K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.8K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

1.8K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.8K
Cancer Survival Analysis01:21

Cancer Survival Analysis

568
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
568

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utilization of real-world evidence in regulatory approvals for multiple myeloma therapies.

Blood cancer journal·2025
Same author

Real-world comparative effectiveness of Bruton tyrosine kinase inhibitors in relapsed/refractory mantle cell lymphoma.

Blood advances·2025
Same author

Racialized economic segregation and inequities in treatment initiation and survival among patients with metastatic breast cancer.

Breast cancer research and treatment·2024
Same author

Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From 2017 to 2022.

JAMA network open·2023
Same author

Culturally Responsive Care Delivery in Oncology: The Example of Multiple Myeloma.

Clinical lymphoma, myeloma & leukemia·2023
Same author

Pull Up a Seat: Engaging Patients as Empowered Partners in Health Equity Transformation.

Journal of the advanced practitioner in oncology·2022

Related Experiment Video

Updated: Dec 14, 2025

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.4K

African American Patients With Multiple Myeloma: Optimizing Care to Decrease Racial Disparities.

Amy Pierre1, Tiffany H Williams2

  • 1Memorial Sloan Kettering Cancer Center.

Clinical Journal of Oncology Nursing
|July 18, 2020
PubMed
Summary
This summary is machine-generated.

African Americans have a higher incidence of multiple myeloma, the leading blood cancer in this group. Delays in diagnosis and treatment access contribute to poorer outcomes, highlighting the need for culturally competent care.

Keywords:
African Americanclinical trialsmultiple myelomaoncologyracial disparities

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.9K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.1K

Related Experiment Videos

Last Updated: Dec 14, 2025

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.4K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.9K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.1K

Area of Science:

  • Hematology
  • Oncology Nursing
  • Health Disparities

Background:

  • Multiple myeloma incidence is 2-3 times higher in African Americans compared to other ethnicities.
  • It is the leading hematologic malignancy among African Americans.
  • African Americans face diagnostic delays, reduced access to therapies like stem cell transplantation, and lower clinical trial participation.

Purpose of the Study:

  • To highlight the significant racial disparities in multiple myeloma incidence and outcomes.
  • To emphasize the barriers to care faced by African American patients.
  • To underscore the importance of understanding unique disease characteristics for optimal oncology nursing care.

Main Methods:

  • This study is a review of existing literature and data on multiple myeloma incidence, treatment, and outcomes in African Americans.
  • Analysis of factors contributing to health disparities in this population.
  • Identification of unique disease manifestations.

Main Results:

  • African Americans exhibit a 2-3 fold higher incidence of multiple myeloma.
  • Significant delays in diagnosis and underutilization of effective treatments are prevalent.
  • Social, financial, and access-to-care barriers exacerbate poorer patient outcomes.

Conclusions:

  • Addressing racial and socioeconomic disparities is crucial for improving multiple myeloma outcomes in African Americans.
  • Oncology nurses must recognize unique disease characteristics for culturally competent and effective patient care.
  • Enhanced early diagnosis and equitable access to advanced therapies are essential.